4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-028740
EVP R&D, Chief Medical Officer sold 9,221 shares at $31.50 ($290,462)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-05 | Sale : show line 1 in the form 10b5-1 | −9,221 | $31.50 | $290,462 | 59,730 | D |
| Open-market sales · 9,221 sh · avg $31.50 · $290,462 | ||||||
Loading xslF345X05/form4.xml…